Hooshmand Sheshbaradaran
Net worth: 317 062 $ as of 30/05/2026
Net worth: 317 062 $ as of 30/05/2026
Hooshmand Sheshbaradaran is the founder of Niiki Pharma, Inc. Current jobs include Director at Bold Therapeutics, Inc. since 2019, Chief Operating Officer at BetterLife Pharma, Inc., and Chief Operating Officer at MedMelior, Inc. since 2018.
Former jobs include Director & Chief Development Officer at Intezyne Technologies, Inc. from 2013 to 2019, Director-Oncology & New Products Marketing at Pfizer Inc., Director-Oncology Business Development at F.
Hoffmann-La Roche Ltd., Director-Oncology & New Products Marketing at Pharmacia Corp., Principal at Cephalon Ltd., and Chief Business Officer at Akamis Bio Ltd. Education includes a doctorate from Karolinska Institutet.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/05/2026 | 6,892,653 ( 4.54% ) | 317 062 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| BETTERLIFE PHARMA INC. | Chief Operating Officer | - |
Niiki Pharma, Inc.
Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Manufactures chemicals and botanical products | Founder | - |
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Develops anti-resistance therapeutic | Director/Board Member | 31/12/2018 |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Engage in business of developing therapeutics for women | Chief Operating Officer | 31/10/2018 |
| Companies | Position | End |
|---|---|---|
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic technologies | Director/Board Member | 01/01/2019 |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Corporate Officer/Principal | - |
| PFIZER INC. | Sales & Marketing | - |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Sales & Marketing | - |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zeneus Pharma Ltd.
Zeneus Pharma Ltd. Medical DistributorsDistribution Services Provides pharmaceutical products | Distribution Services |
Niiki Pharma, Inc.
Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Manufactures chemicals and botanical products | Health Technology |
BetterLife Pharma, Inc.
BetterLife Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of therapeutic pharmaceutical products | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic technologies | Commercial Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Engage in business of developing therapeutics for women | Health Technology |
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Develops anti-resistance therapeutic | Health Technology |
Select your edition
All financial news and data tailored to specific country editions